NCT03560804View on ClinicalTrials.gov

Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 10, 2014

Primary Completion Date

September 15, 2017

Study Completion Date

September 15, 2017

Conditions
Arterial StiffnessAmbulatory Blood Pressure Monitoring
Interventions
DRUG

Olmesartan

Administration of olmesartan at starting dose and titrating in order to reach the target blood pressure.

DRUG

Chlorthalidone

Administration of chlorthalidone at starting dose and titrating in order to reach the target blood pressure.

Trial Locations (1)

54635

Hypertension Excellence Center, AHEPA University Hospital, Thessaloniki

All Listed Sponsors
lead

AHEPA University Hospital

OTHER

NCT03560804 - Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs | Biotech Hunter | Biotech Hunter